Schedule 13G ownership disclosure

Akers Biosciences Inc

Security class unavailable · CUSIP: 00973E102

Event date: 2017-03-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
724,200
Percent of class
8.4500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-17-001896
Form type
SC 13G
Filer
Q/C TECHNOLOGIES, INC.
CIK
CIK 1321834
Filed
Apr 07, 2017
Reporting period
Mar 30, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub